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Five years ago a surprising discovery was made-that certain
synthetic preparations, themselves not chemically related to the
naturally occurring estrogens, give rise to estrogenic responses when
administered to suitable animals.2
Recently the estrogenic activity of di-ethyl-stilbene (stilbes-
trol)-not chemically related to estrin-was described by Dodds
and his associates.3 This synthetic material appeared to be about
two and a half times as effective as estrone in promoting vaginal,
uterine, and mammary changes in laboratory animals. Otherwise,
the physiological responses resembled those induced by administer-
ing estrone. Stilbestrol has the great advantage in practice of
being inexpensive to manufacture and it is suitable for oral
administration.
More recently still, Bishop and his co-workers1 found that stil-
bestrol injected into the spayed rhesus monkey would produce
results exactly like those obtained after administering natural estro-
gens. A number of women patients treated orally also showed
definite and satisfactory estrogenic responses, although some were
nauseated and even vomited after taking the drug.
On the same day that Bishop's article appeared, two others de-
scribing like results in women were published by Winterton and by
Loeser.4 5 Patients with various menstrual disturbances and vaginal
atrophy were treated with stilbestrol orally. The results were excel-
lent, although occasionally nausea was produced.
Since there has been hardly more than mention of stilbestrol
in the literature of this country, it seemed worth while to investigate
its use in different types of cases. This is a brief report on the results.
It seemed advisable first to repeat some of the observations made
by others and to see whether the dramatic physiologic response pro-
duced by the natural estrogens in girls and in women could be repro-
duced with stilbestrol. Beyond this it was of interest to determine
its value as a therapeutic agent.
Summarizing briefly the more striking and easily demonstrable
effects of the estrogens when given to the human female, one may
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say that: (I) given before or after the years of ovarian activity,
usually evidenced by menstruation, estrogens bring about striking
proliferative changes of the vaginal mucosa, simultaneously produc-
ing an acid vaginal secretion; (2) endometrial proliferation to a
midinterval stage is observed; (3) sufficient dosage often produces
uterine bleeding (menstruation), although this may occur only after
the estrogens are discontinued; (4) Hartman and Zuckerman have
shown that the phenomenon of menstruation may be postponed in
monkeys if the administration of estrin is begun early in the pre-
ovulatory part of the menstrual cycle; and (5) in children and in
castrates pigmentation of the nipples and mammary growth may be
produced by giving a sufficient amount of estrogens over a long
enough period of time.
In the different cases mentioned here all of these physiological
changes with the exception of (2), were seen after taking stilbes-
trol orally. Uterine bleeding was taken asevidence that endometrial
proliferation had occurred, and it was not thought necessary to
curette a patient to prove this point.
Altogether, eight girls have been treated with stilbestrol. To
four the drug was given by mouth, while to the remainder it was
given in the form of vaginal suppositories, each containing 1 mg. of
stilbestrol. All of these patients showed the expected and charac-
teristic vulvar hypertrophy, as well as a proliferation of the vaginal
mucosa with the production of acid vaginal "secretions."
Each of three girls was given one pill, containing 5 mg. of
stilbestrol, daily for 17 days. At the end of this time the nipples
of all of them had changed from the usual pink color to such a dark
brown as to be almost black. One child showed a very slight breast
enlargement, which disappeared after stopping the drug. One 10-
year-old child received 1 mg. of stilbestrol daily for 21 days. In
this case bronzing of the nipples and a moderate hypertrophy of the
breasts were produced, in addition to the usual vaginal changes.
Speaking very generally, patients suffering with menopausal
symptoms fall into two major classes:-
1) Those suffering almost entirely from vasomotor disturbances,
including hot flashes, headache (usually frontal), and a peculiar
type of vertigo.
2) Those in whom these symptoms are subordinate; who present
what we may call evidences of nervous or psychic disorder.
I believe that the majority of the former group can be relieved
if sufficient estrogens are given. The latter group yield unsatis-
factory results to estrogenic therapy.
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Unlike Shorre and Papanikalaoun, it is our belief that to relieve
vasomotor symptoms one must often give more estrogens than are
needed to produce vaginal changes. In all likelihood insufficient
dosage has often accounted for failure in these cases.
Ten women with typical vasomotor menopausal disturbances
were treated (office patients). They were chosen as having few
accompanying nervous symptoms. While Parkes and Dodds report
three of fifty-one patients unable to take stilbestrol because of
vomiting, I was less successful in that two of the ten became nause-
ated and were unable to continue taking the drug. Of the remaining
eight patients, six obtained complete relief from their hot flashes,
while the accompanying headache and dizziness improved or were
entirely cured. One patient was entirely relieved for three months,
but has just reported nausea. One was not benefited.
In some of the cases treated, relief was astonishingly prompt.
As a rule, before beginning treatment I have had patients with
menopausal disturbances keep a chart for a week, checking each 24
hours the number of times that they experienced the so-called hot
flashes as they occur, and specifying each time whether the symptom
was mild, moderate, or severe. A further note is made at the end
of the day on the presence or absence of headache and vertigo. This
helps in determining the severity of symptoms in any given case,
and helps both patient and physician to decide how much or how
little benefit is conferred by any given treatment.
The case of Mrs. Z, aet. 42, illustrates the results which may be hoped
for. On Dec. 1, 1938, I removed her uterus, tubes, and ovaries. Recovery
was uneventful and the patient returned to her home in two weeks. Early
in January she again took to her bed, stating that headache and dizziness
made it impossible for her to be comfortable if she moved about. "Hot
flashes" disturbed her day and night. Her chart at the week's end showed
that she averaged thirty "hot flashes" each 24 hours, that headache was
constant during the day, and that dizziness was frequent. Phenobarbital
and other sedatives were given without benefit.
On March 1 she was instructed to take one pill containing 5 mg. of
stilbestrol daily by mouth. Three days later improvement was marked.
"Hot flashes" were no longer experienced. Headache and vertigo were
absent by the end of the week. The dose of stilbestrol was soon reduced to
2 mg., alternating with 1 mg. daily. During subsequent months the patient
has remained symptomless except when pills were purposely omitted several
times. On each of these occasions the disturbing symptoms returned within
three days. It is important to note that in her case stilbestrol, though given
freely, caused no nausea or vomiting at any time.
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In the other cases, the results, while not as spectacular, were
equally satisfactory. Two of the patients treated for menopausal
vasomotor disturbances also showed atrophy of the vaginal mucosa
with a nearly neutral reaction of the vaginal secretions. After three
weeks' treatment with stilbestrol, squamous cell proliferation and
normal vaginal acidity were present.
Two women, well past the menopause, had uterine (menstrual)
bleedingwhile under treatment. One of them has had three periods
of bleeding, though not at regular intervals.
Three other patients with senile vaginitis and vulvar atrophy
were not much, if at all, benefited symptomatically by taking stil-
bestrol, although hypertrophy of the vaginal mucosa was brought
about by the treatment.
Conclusions
The physiological response of women treated with the synthetic
drug stilbestrol appears to be the same as that elicited by the
administration of the natural estrogens.
The cost of manufacturing stilbestrol is less than is the cost of
preparing the natural estrogens.
The fact that stilbestrol is effective when given orally is
advantageous.
Stilbestrol may produce nausea and even vomiting in some
cases, contraindicating its further use.
It is suggested that patients, when given this or any other estro-
gen, be also given periods of several weeks' rest from the drug at
intervals. There are possible risks in long-continued uninterrupted
stimulation of the genital tract and breasts.
It should be emphasized that this paper makes no attempt at a
statistical statement of results. For example, a number of patients
with menopausal disturbances other than vasomotor have been
treated with less success than those in the carefully selected group
mentioned. There is reason to believe, also, that nausea and vomit-
ing result more often than this paper would suggest.
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The stilbestrol used in the treatment of these cases was made and supplied free
by E. R. Squibb & Co.